PATENT CLAIM ANALYSIS

Application Number: 15778220
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "027000"]

Abstract:
This present invention relates to a complex of a glucopyranosyl derivative and L-pyroglutamic acid as a sodium dependent glucose cotransporter (SGLT) inhibitor, and preparation processes thereof, and a pharmaceutical composition containing the complex, and their uses in the manufacture of a medicament for treating diabetes and/or diabetes-related diseases.

Claim (Index 27):
A method of inhibiting SGLT-2, inhibiting SGLT-1, elevating the high density lipoprotein level, preventing, treating, lessening or delaying a disease in a patient comprising administering a therapeutically effective amount of the complex of  claim 1  to the patient, wherein the disease is diabetes, a diabetic complication, insulin resistance, hyperglycemia, hyperinsulinemia, elevated blood levels of fatty acids or glycerol, hyperlipidemia, obesity, syndrome X, atherosclerosis or hypertension,\n wherein diabetic complication compromises at least of one of diabetic retinopathy, diabetic neuropathy, diabetic nephropathy; \n wherein hyperlipidemia compromises hypertriglyceridemia.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 93.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14627693', '15804074', '13158724', '12503225', '13530645']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7697438123364341
- 35 USC 102 Novelty (BERT): 0.5151984768469445
- Combined Prediction Score: 0.7442892787874851
- Mean Citation Score: 259.12978200000003
- Max Citation Score: 287.61752
- Similarity Product: 185.4806368512201

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test